Stephanie Stuteley
2024: Dr Stephanie Stuteley (Ngāti Tarāwhai, Ngāti Pikiao) of Waipapa Taumata Rau The University of Auckland will research a promising new method for treatment of tuberculosis (TB)
Antimicrobial resistance is an urgent global health threat, particularly for TB, which causes nearly one third of deaths from drug-resistant infections. TB bacteria produce proteins containing iron-sulfur clusters which it uses to counteract both the host's immune system and a major class of anti-TB drugs. Dr Stuteley has already established the only facility in Aotearoa New Zealand equipped to produce and study these iron-sulfur proteins, which requires oxygen-free conditions. Dr Stuteley will study the biochemical pathways which produce these iron-sulfur clusters in TB bacteria and how these protective pathways can be disrupted. This project will generate essential new knowledge for the development of new TB treatments.
Dr Stephanie Stuteley (Supplied)